GSK Ownership | Who Owns GSK?
GSK Ownership Summary
GSK is owned by 7.57% institutional investors, 0.06% insiders, and 92.37% retail investors. Dodge & cox is the largest institutional shareholder, holding 1.68% of GSK shares. Dodge & Cox Stock I is the top mutual fund, with 2.45% of its assets in GSK shares.
GSK Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | GSK | 7.57% | 0.06% | 92.37% |
Sector | Healthcare Stocks | 46.80% | 8.14% | 45.06% |
Industry | Drug Manufacturers - General Stocks | 55.48% | 0.09% | 44.43% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Dodge & cox | 68.34M | 1.68% | $2.63B |
Fmr | 26.78M | 0.66% | $1.03B |
Jtc employer solutions trustee | 20.88M | 0.51% | $803.79M |
Fisher asset management | 17.71M | 0.44% | $681.70M |
Primecap management co/ca/ | 14.51M | 0.36% | $558.69M |
Price t rowe associates inc /md/ | 10.23M | 0.25% | $393.94M |
Morgan stanley | 10.11M | 0.25% | $389.18M |
Royal bank of canada | 7.04M | 0.17% | $271.07M |
State street | 6.80M | 0.17% | $264.46M |
Holocene advisors, lp | 5.69M | 0.14% | $219.05M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Jtc employer solutions trustee | 20.88M | 53.74% | $803.79M |
Eversept partners, lp | 3.47M | 9.14% | $133.52M |
Callodine capital management, lp | 540.00K | 4.85% | $20.79M |
Equity investment | 3.43M | 3.38% | $132.18M |
Robinson value management | 116.46K | 3.12% | $4.48M |
Clean yield group | 210.56K | 3.03% | $8.11M |
Clifford capital partners | 358.29K | 3.00% | $13.79M |
Mondrian investment partners | 4.90M | 2.92% | $189.89M |
Camber capital management lp | 2.67M | 2.85% | $102.99M |
Provident trust | 3.89M | 2.78% | $149.64M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Fmr | 26.78M | 0.07% | 2.20M |
Lmr partners llp | 3.33M | 1.08% | 2.10M |
Fisher asset management | 17.71M | 0.30% | 2.04M |
Primecap management co/ca/ | 14.51M | 0.40% | 1.77M |
Deutsche bank ag\ | 1.75M | 0.03% | 1.74M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Holocene advisors, lp | 5.69M | 0.91% | -3.03M |
Morgan stanley | 10.11M | 0.03% | -2.36M |
Citigroup | 653.08K | 0.02% | -1.76M |
Magnetar financial | - | - | -1.65M |
Adage capital partners gp | - | - | -1.30M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Healthcare of ontario pension plan trust fund | 1.36M | 0.15% | 1.36M | $52.49M |
Manning & napier advisors | 150.00K | 0.07% | 150.00K | $5.78M |
Connor, clark & lunn investment management | 108.61K | 0.02% | 108.61K | $4.18M |
Unisuper management pty | 96.48K | 0.03% | 96.48K | $3.71M |
Drucker wealth 3.0 | 82.18K | 0.84% | 82.18K | $3.16M |
Sold Out
Holder | Change |
---|---|
Cedar mountain advisors | -17.00 |
Hoey investments | -19.00 |
Financial gravity asset management | -23.00 |
Chris bulman | -26.00 |
Abich financial wealth management | -50.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 873 | -5.72% | 308,017,843 | -1.01% | 7 | 12.95% | 377 | -11.71% | 293 | -2.01% |
Mar 31, 2024 | 926 | 1.76% | 311,145,368 | 7.01% | 7 | 14.88% | 427 | 7.29% | 299 | -9.67% |
Dec 31, 2023 | 910 | 5.20% | 290,762,598 | 1.94% | 7 | 14.49% | 398 | 1.27% | 331 | 22.14% |
Sep 30, 2023 | 865 | 2.98% | 285,233,211 | 2.83% | 7 | 15.02% | 393 | 5.93% | 271 | -0.37% |
Jun 30, 2023 | 840 | 0.48% | 277,372,611 | 1.92% | 6 | 15.11% | 371 | -14.32% | 272 | 22.52% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Dodge & Cox Stock I | 50.05M | 2.45% | - |
Vanguard PRIMECAP Inv | 10.36M | 0.51% | 224.38K |
Dodge & Cox Balanced Composite | 4.80M | 0.24% | -176.00K |
Dodge & Cox Balanced I | 4.80M | 0.24% | -176.00K |
T. Rowe Price International Val Eq Tr- A | 3.81M | 0.19% | 36.84K |
T. Rowe Price International Value Eq | 3.17M | 0.16% | - |
T. Rowe Price International Value Equity | 3.17M | 0.16% | -9.67K |
Fidelity Series Large Cap Stock | 3.15M | 0.15% | - |
Strategic Advisers Fidelity US TtlStk | 2.52M | 0.12% | - |
Vanguard PRIMECAP Core Inv | 2.16M | 0.11% | 33.76K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2023 Q1 | - | - |
2022 Q4 | - | - |
2021 Q3 | 1 | - |
2021 Q2 | - | - |
2018 Q3 | 1 | - |
GSK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools